DoseGear research brief
Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile.
EDR
Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement
DoseGear research brief
Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile.
Penetrates nuclear membranes to directly interact with DNA, modulates gene expression via histone H1. 3 binding and MAPK/ERK pathway activation.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Synthetic EDR tripeptide associated with Khavinson research.
Experimental neuronal protection and cognition involving oxidative-stress, apoptosis, and gene-regulatory effects.
The source cites 14-day diabetic-rat and 28-day intraperitoneal 5xFAD-mouse experiments; a human response window is not established.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Neuroprotection | 5mg daily | Once daily | SubQ |
| Cognitive Enhancement | 100-300mcg | Daily or every other day | SubQ |
| Anti-aging | 5mg | 20 days, 2-3x yearly | SubQ |
Reference cycle
20 days per cycle
Reference storage
Refrigerate at 2-8°C, use within 30 days after reconstitution
Human Clinical Trial - Post-Traumatic Cerebrasthenia
Aging Study - Polymorbidity Patients
Diabetic Rat Model - Spatial Learning
5xFAD Alzheimer's Mouse Model
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.